Exelixis (EXEL) Price/FCF Ratio: History & Chart

Exelixis, Inc.(EXEL)

Biotechnology · Alameda, CA

$54.08+0.39 (+0.73%)

Delayed quote: Aug 21, 2026, 4:00 PM EDT

About Exelixis, Inc.

Exelixis, Inc. operates as a biotechnology firm dedicated to combating cancer, primarily focusing on the identification, advancement, and marketing of novel oncological treatments within the United States. Its portfolio of commercially available therapeutics includes CABOMETYX tablets, prescribed for individuals with advanced renal cell carcinoma who have previously undergone anti-angiogenic treatment, and COMETRIQ capsules, utilized for managing progressive and metastatic medullary thyroid cancer. Both CABOMETYX and COMETRIQ originate from cabozantinib, a compound that inhibits several tyrosine kinases such as MET, AXL, RET, and VEGF receptors. Additionally, Exelixis offers COTELLIC, an MEK inhibitor employed in combination therapies for advanced melanoma, and MINNEBRO, an orally administered, non-steroidal selective mineralocorticoid receptor blocker, approved for hypertension treatment in Japan. The company's developmental pipeline features several promising candidates, such as XL092, an oral tyrosine kinase inhibitor designed to target VEGF receptors, MET, AXL, MER, and other kinases crucial for cancer proliferation; XB002, an antibody-drug conjugate containing a human monoclonal antibody against tissue factor (TF), intended for advanced solid tumors and non-Hodgkin's lymphoma; and XL102, an orally available cyclin-dependent kinase 7 (CDK7) inhibitor being developed for advanced or metastatic solid tumors. Exelixis, Inc. maintains extensive research partnerships and licensing arrangements with numerous pharmaceutical and biotechnology entities, including Ipsen Pharma SAS, Takeda Pharmaceutical Company Ltd., F. Hoffmann-La Roche Ltd., Redwood Bioscience, Inc., R.P. Scherer Technologies, LLC, Catalent Pharma Solutions, Inc., NBE Therapeutics AG, Aurigene Discovery Technologies Limited, Iconic Therapeutics, Inc., Invenra, Inc., StemSynergy Therapeutics, Inc., Genentech, Inc., Bristol-Myers Squibb Company, and Daiichi Sankyo Company, Limited. Established in 1994, the company originally operated as Exelixis Pharmaceuticals, Inc. before rebranding to Exelixis, Inc. in February 2000. Its corporate headquarters are located in Alameda, California.

Alameda, CA

1,077 employees

www.exelixis.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael Morrissey

View full financials

EXEL Price/FCF Ratio Metrics

PRICE/FCF RATIO

11.89

PRICE/FCF RATIO AVG TTM

15.27

PRICE/FCF RATIO AVG 3Y

27.13

PRICE/FCF RATIO AVG 5Y

26.19

PRICE/FCF RATIO AVG 10Y

29.27

PRICE/FCF RATIO AVG 15Y

29.34

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-22.14%

CURRENT VS 3Y AVG

-56.17%

CURRENT VS 5Y AVG

-54.61%

CURRENT VS 10Y AVG

-59.38%

CURRENT VS 15Y AVG

-59.47%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

22.81

median of 73 covered companies

CURRENT VS SECTOR MEDIAN

-47.87%

vs the sector median at left

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Exelixis, Inc. (EXEL)	$13.59B	11.89	15.27	27.13	26.19
Baxter International Inc. (BAX)vs ›	$13.62B	20.18	30.13	30.38	29.77
Revvity, Inc. (RVTY)vs ›	$13.92B	24.92	22.51	200.45	127.64
Charles River Laboratories International, Inc. (CRL)vs ›	$14.22B	38.13	19.21	22.23	27.89
Tempus AI, Inc. (TEM)vs ›	$12.74B	N/A	N/A	N/A	N/A
The Cooper Companies, Inc. (COO)vs ›	$14.87B	26.08	31.24	70.10	57.12
Solventum Corporation (SOLV)vs ›	$15.51B	N/A	116.92	65.01	65.01
Align Technology, Inc. (ALGN)vs ›	$11.64B	15.07	18.62	28.81	38.65
Bio-Techne Corporation (TECH)vs ›	$11.32B	43.14	38.58	43.91	47.95
DaVita Inc. (DVA)vs ›	$11.16B	7.20	8.53	8.81	8.65

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Exelixis, Inc. (EXEL)

$13.59B

11.89

15.27

27.13

26.19

Baxter International Inc. (BAX)vs ›

$13.62B

20.18

30.13

30.38

29.77

Revvity, Inc. (RVTY)vs ›

$13.92B

24.92

22.51

200.45

127.64

Charles River Laboratories International, Inc. (CRL)vs ›

$14.22B

38.13

19.21

22.23

27.89

Tempus AI, Inc. (TEM)vs ›

$12.74B

N/A

The Cooper Companies, Inc. (COO)vs ›

$14.87B

26.08

31.24

70.10

57.12

Solventum Corporation (SOLV)vs ›

$15.51B

N/A

116.92

65.01

Align Technology, Inc. (ALGN)vs ›

$11.64B

15.07

18.62

28.81

38.65

Bio-Techne Corporation (TECH)vs ›

$11.32B

43.14

38.58

43.91

47.95

DaVita Inc. (DVA)vs ›

$11.16B

7.20

8.53

8.81

8.65

Price/FCF Ratio FAQ

What is the Price/FCF ratio for Exelixis, Inc. (EXEL)?

The Price/FCF ratio for EXEL stock is 11.89.

Is Exelixis, Inc.'s Price/FCF ratio high or low?

The Price/FCF ratio of 11.89 is 55% below its 5-year average of 26.19, near the low end of its 5-year range (11.08–57.43).

What is the TTM average Price/FCF ratio for Exelixis, Inc. (EXEL)?

The TTM average Price/FCF ratio for EXEL stock is 15.27.

What is the 3Y average Price/FCF ratio for Exelixis, Inc. (EXEL)?

The 3Y average Price/FCF ratio for EXEL stock is 27.13.

What is the 5Y average Price/FCF ratio for Exelixis, Inc. (EXEL)?

The 5Y average Price/FCF ratio for EXEL stock is 26.19.

What is the 10Y average Price/FCF ratio for Exelixis, Inc. (EXEL)?

The 10Y average Price/FCF ratio for EXEL stock is 29.27.

What is the 15Y average Price/FCF ratio for Exelixis, Inc. (EXEL)?

The 15Y average Price/FCF ratio for EXEL stock is 29.34.

DATE	PRICE/FCF RATIO
2026-08-21	11.89
2026-08-20	11.81
2026-08-19	11.96
2026-08-18	11.68
2026-08-17	11.51
2026-08-14	11.27
2026-08-13	11.13
2026-08-12	11.08
2026-08-11	11.29
2026-08-10	11.65
2026-08-07	11.89
2026-08-06	11.48
2026-08-05	12.47
2026-08-04	16.34
2026-08-03	16.06
2026-07-31	15.47
2026-07-30	16.33
2026-07-29	16.14
2026-07-28	16.48
2026-07-27	16.28
2026-07-24	16.15
2026-07-23	16.23
2026-07-22	16.04
2026-07-21	16.37
2026-07-20	16.20
2026-07-17	16.31
2026-07-16	16.24
2026-07-15	16.20
2026-07-14	16.27
2026-07-13	16.35
2026-07-10	16.48
2026-07-09	16.66
2026-07-08	16.37
2026-07-07	16.65
2026-07-06	16.20
2026-07-02	16.29
2026-07-01	15.74
2026-06-30	15.87
2026-06-29	15.83
2026-06-26	15.98
2026-06-25	15.53
2026-06-24	15.42
2026-06-23	14.98
2026-06-22	14.98
2026-06-18	15.14
2026-06-17	15.30
2026-06-16	15.20
2026-06-15	15.46
2026-06-12	15.50
2026-06-11	15.61
2026-06-10	15.34
2026-06-09	15.46
2026-06-08	15.09
2026-06-05	15.37
2026-06-04	15.31
2026-06-03	15.05
2026-06-02	14.16
2026-06-01	14.67
2026-05-29	14.73
2026-05-28	15.01
2026-05-27	14.59
2026-05-26	14.58
2026-05-22	14.63
2026-05-21	14.48
2026-05-20	14.56
2026-05-19	14.20
2026-05-18	14.54
2026-05-15	14.62
2026-05-14	14.91
2026-05-13	14.96
2026-05-12	14.43
2026-05-11	14.50
2026-05-08	14.05
2026-05-07	13.48
2026-05-06	14.21
2026-05-05	12.96
2026-05-04	14.55
2026-05-01	14.39
2026-04-30	14.65
2026-04-29	14.72
2026-04-28	14.80
2026-04-27	14.71
2026-04-24	14.80
2026-04-23	15.17
2026-04-22	15.43
2026-04-21	15.12
2026-04-20	14.37
2026-04-17	14.79
2026-04-16	14.62
2026-04-15	14.59
2026-04-14	15.11
2026-04-13	14.81
2026-04-10	14.58
2026-04-09	14.96
2026-04-08	14.56
2026-04-07	14.49
2026-04-06	14.49
2026-04-02	14.46
2026-04-01	14.51
2026-03-31	14.13
2026-03-30	13.82
2026-03-27	13.68
2026-03-26	13.95
2026-03-25	14.10
2026-03-24	13.69
2026-03-23	13.64
2026-03-20	13.60
2026-03-19	13.59
2026-03-18	13.59
2026-03-17	13.78
2026-03-16	13.53
2026-03-13	13.59
2026-03-12	13.56
2026-03-11	13.75
2026-03-10	13.60
2026-03-09	13.96
2026-03-06	13.69
2026-03-05	13.60
2026-03-04	13.73
2026-03-03	13.42
2026-03-02	13.52
2026-02-27	14.52
2026-02-26	14.59
2026-02-25	14.74
2026-02-24	14.87
2026-02-23	14.50
2026-02-20	14.37
2026-02-19	14.55
2026-02-18	14.65
2026-02-17	14.52
2026-02-13	14.47
2026-02-12	14.07
2026-02-11	14.15
2026-02-10	14.16
2026-02-09	16.33
2026-02-06	16.31
2026-02-05	15.75
2026-02-04	15.85
2026-02-03	15.83
2026-02-02	15.91
2026-01-30	15.37
2026-01-29	15.71
2026-01-28	15.85
2026-01-27	16.25
2026-01-26	16.21
2026-01-23	16.45
2026-01-22	16.54
2026-01-21	16.65
2026-01-20	16.27
2026-01-16	16.34
2026-01-15	16.89
2026-01-14	16.81
2026-01-13	16.38
2026-01-12	16.37
2026-01-09	16.37
2026-01-08	16.41
2026-01-07	17.17
2026-01-06	16.23
2026-01-05	15.76
2026-01-02	16.20
2025-12-31	16.29
2025-12-30	16.37
2025-12-29	16.86
2025-12-26	17.18
2025-12-24	17.28
2025-12-23	17.32
2025-12-22	17.17
2025-12-19	16.46
2025-12-18	15.82
2025-12-17	15.61
2025-12-16	15.46
2025-12-15	15.38
2025-12-12	15.19
2025-12-11	15.38
2025-12-10	15.26
2025-12-09	15.56
2025-12-08	15.67
2025-12-05	16.49
2025-12-04	16.49
2025-12-03	16.35
2025-12-02	16.14
2025-12-01	16.14
2025-11-28	16.41
2025-11-26	16.43
2025-11-25	16.03
2025-11-24	15.70
2025-11-21	15.80
2025-11-20	15.53
2025-11-19	15.66
2025-11-18	15.85
2025-11-17	15.76
2025-11-14	15.48
2025-11-13	15.74
2025-11-12	16.20
2025-11-11	15.97
2025-11-10	15.39
2025-11-07	15.17
2025-11-06	15.16
2025-11-05	15.00
2025-11-04	14.08
2025-11-03	14.97
2025-10-31	15.21
2025-10-30	15.32
2025-10-29	15.51
2025-10-28	15.77
2025-10-27	15.73
2025-10-24	15.23
2025-10-23	14.97
2025-10-22	14.20
2025-10-21	14.22
2025-10-20	13.59
2025-10-17	15.44
2025-10-16	15.43
2025-10-15	15.75
2025-10-14	15.55
2025-10-13	15.12
2025-10-10	15.01
2025-10-09	15.18
2025-10-08	15.20
2025-10-07	15.59
2025-10-06	15.74
2025-10-03	15.77
2025-10-02	16.27
2025-10-01	16.21
2025-09-30	16.25
2025-09-29	15.96
2025-09-26	15.36
2025-09-25	15.22
2025-09-24	15.31
2025-09-23	15.66
2025-09-22	15.57
2025-09-19	15.78
2025-09-18	15.92
2025-09-17	15.91
2025-09-16	15.40
2025-09-15	15.35
2025-09-12	15.40
2025-09-11	15.37
2025-09-10	14.83
2025-09-09	15.06
2025-09-08	14.83
2025-09-05	14.90
2025-09-04	14.71
2025-09-03	14.54
2025-09-02	14.63
2025-08-29	14.72
2025-08-28	14.91
2025-08-27	15.15
2025-08-26	15.08
2025-08-25	14.91
2025-08-22	15.20
2025-08-21	15.23
2025-08-20	14.90
2025-08-19	14.76
2025-08-18	14.86
2025-08-15	15.07
2025-08-14	15.14
2025-08-13	15.14
2025-08-12	14.93
2025-08-11	14.72

DATE

PRICE/FCF RATIO

2026-08-21

11.89

2026-08-20

11.81

2026-08-19

11.96

2026-08-18

11.68

2026-08-17

11.51

2026-08-14

11.27

2026-08-13

11.13

2026-08-12

11.08

2026-08-11

11.29

2026-08-10

11.65

2026-08-07

11.89

2026-08-06

11.48

2026-08-05

12.47

2026-08-04

16.34

2026-08-03

16.06

2026-07-31

15.47

2026-07-30

16.33

2026-07-29

16.14

2026-07-28

16.48

2026-07-27

16.28

2026-07-24

16.15

2026-07-23

16.23

2026-07-22

16.04

2026-07-21

16.37

2026-07-20

16.20

2026-07-17

16.31

2026-07-16

16.24

2026-07-15

16.20

2026-07-14

16.27

2026-07-13

16.35

2026-07-10

16.48

2026-07-09

16.66

2026-07-08

16.37

2026-07-07

16.65

2026-07-06

16.20

2026-07-02

16.29

2026-07-01

15.74

2026-06-30

15.87

2026-06-29

15.83

2026-06-26

15.98

2026-06-25

15.53

2026-06-24

15.42

2026-06-23

14.98

2026-06-22

14.98

2026-06-18

15.14

2026-06-17

15.30

2026-06-16

15.20

2026-06-15

15.46

2026-06-12

15.50

2026-06-11

15.61

2026-06-10

15.34

2026-06-09

15.46

2026-06-08

15.09

2026-06-05

15.37

2026-06-04

15.31

2026-06-03

15.05

2026-06-02

14.16

2026-06-01

14.67

2026-05-29

14.73

2026-05-28

15.01

2026-05-27

14.59

2026-05-26

14.58

2026-05-22

14.63

2026-05-21

14.48

2026-05-20

14.56

2026-05-19

14.20

2026-05-18

14.54

2026-05-15

14.62

2026-05-14

14.91

2026-05-13

14.96

2026-05-12

14.43

2026-05-11

14.50

2026-05-08

14.05

2026-05-07

13.48

2026-05-06

14.21

2026-05-05

12.96

2026-05-04

14.55

2026-05-01

14.39

2026-04-30

14.65

2026-04-29

14.72

2026-04-28

14.80

2026-04-27

14.71

2026-04-24

14.80

2026-04-23

15.17

2026-04-22

15.43

2026-04-21

15.12

2026-04-20

14.37

2026-04-17

14.79

2026-04-16

14.62

2026-04-15

14.59

2026-04-14

15.11

2026-04-13

14.81

2026-04-10

14.58

2026-04-09

14.96

2026-04-08

14.56

2026-04-07

14.49

2026-04-06

14.49

2026-04-02

14.46

2026-04-01

14.51

2026-03-31

14.13

2026-03-30

13.82

2026-03-27

13.68

2026-03-26

13.95

2026-03-25

14.10

2026-03-24

13.69

2026-03-23

13.64

2026-03-20

13.60

2026-03-19

13.59

2026-03-18

13.59

2026-03-17

13.78

2026-03-16

13.53

2026-03-13

13.59

2026-03-12

13.56

2026-03-11

13.75

2026-03-10

13.60

2026-03-09

13.96

2026-03-06

13.69

2026-03-05

13.60

2026-03-04

13.73

2026-03-03

13.42

2026-03-02

13.52

2026-02-27

14.52

2026-02-26

14.59

2026-02-25

14.74

2026-02-24

14.87

2026-02-23

14.50

2026-02-20

14.37

2026-02-19

14.55

2026-02-18

14.65

2026-02-17

14.52

2026-02-13

14.47

2026-02-12

14.07

2026-02-11

14.15

2026-02-10

14.16

2026-02-09

16.33

2026-02-06

16.31

2026-02-05

15.75

2026-02-04

15.85

2026-02-03

15.83

2026-02-02

15.91

2026-01-30

15.37

2026-01-29

15.71

2026-01-28

15.85

2026-01-27

16.25

2026-01-26

16.21

2026-01-23

16.45

2026-01-22

16.54

2026-01-21

16.65

2026-01-20

16.27

2026-01-16

16.34

2026-01-15

16.89

2026-01-14

16.81

2026-01-13

16.38

2026-01-12

16.37

2026-01-09

16.37

2026-01-08

16.41

2026-01-07

17.17

2026-01-06

16.23

2026-01-05

15.76

2026-01-02

16.20

2025-12-31

16.29

2025-12-30

16.37

2025-12-29

16.86

2025-12-26

17.18

2025-12-24

17.28

2025-12-23

17.32

2025-12-22

17.17

2025-12-19

16.46

2025-12-18

15.82

2025-12-17

15.61

2025-12-16

15.46

2025-12-15

15.38

2025-12-12

15.19

2025-12-11

15.38

2025-12-10

15.26

2025-12-09

15.56

2025-12-08

15.67

2025-12-05

16.49

2025-12-04

16.49

2025-12-03

16.35

2025-12-02

16.14

2025-12-01

16.14

2025-11-28

16.41

2025-11-26

16.43

2025-11-25

16.03

2025-11-24

15.70

2025-11-21

15.80

2025-11-20

15.53

2025-11-19

15.66

2025-11-18

15.85

2025-11-17

15.76

2025-11-14

15.48

2025-11-13

15.74

2025-11-12

16.20

2025-11-11

15.97

2025-11-10

15.39

2025-11-07

15.17

2025-11-06

15.16

2025-11-05

15.00

2025-11-04

14.08

2025-11-03

14.97

2025-10-31

15.21

2025-10-30

15.32

2025-10-29

15.51

2025-10-28

15.77

2025-10-27

15.73

2025-10-24

15.23

2025-10-23

14.97

2025-10-22

14.20

2025-10-21

14.22

2025-10-20

13.59

2025-10-17

15.44

2025-10-16

15.43

2025-10-15

15.75

2025-10-14

15.55

2025-10-13

15.12

2025-10-10

15.01

2025-10-09

15.18

2025-10-08

15.20

2025-10-07

15.59

2025-10-06

15.74

2025-10-03

15.77

2025-10-02

16.27

2025-10-01

16.21

2025-09-30

16.25

2025-09-29

15.96

2025-09-26

15.36

2025-09-25

15.22

2025-09-24

15.31

2025-09-23

15.66

2025-09-22

15.57

2025-09-19

15.78

2025-09-18

15.92

2025-09-17

15.91

2025-09-16

15.40

2025-09-15

15.35

2025-09-12

15.40

2025-09-11

15.37

2025-09-10

14.83

2025-09-09

15.06

2025-09-08

14.83

2025-09-05

14.90

2025-09-04

14.71

2025-09-03

14.54

2025-09-02

14.63

2025-08-29

14.72

2025-08-28

14.91

2025-08-27

15.15

2025-08-26

15.08

2025-08-25

14.91

2025-08-22

15.20

2025-08-21

15.23

2025-08-20

14.90

2025-08-19

14.76

2025-08-18

14.86

2025-08-15

15.07

2025-08-14

15.14

2025-08-13

15.14

2025-08-12

14.93

2025-08-11

14.72

Price/FCF Ratio: 11.89

EXEL Price/FCF Ratio Chart

EXEL Average Price/FCF Ratio Chart

EXEL Current vs Average Price/FCF Ratio Chart

EXEL Price/FCF Ratio Metrics

EXEL Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Price/FCF Ratio FAQ

EXEL Price/FCF Ratio History

Related Metrics